Approach to a Liver Mass

Clinics in Liver Disease

Volumn 13, Issue 2, 2009, Pages 193-210

  Shaked, Oren ^a   Reddy, K Rajender ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenoma; Benign liver mass; Cystadenoma; Diagnostic tools; FNH; Hemangioma; NRH; Simple cyst

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; TECHNETIUM SULFUR COLLOID TC 99M;

BENIGN TUMOR; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOMA; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER ADENOMA; LIVER BIOPSY; LIVER CYST; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER INJURY; LIVER TUMOR; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGIST; REVIEW; TISSUE SECTION; TUMOR DIAGNOSIS;

DIAGNOSTIC IMAGING; HUMANS; LIVER; LIVER DISEASES;

EID: 65549127312     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2009.02.004     Document Type: Review

References (97)

1. Gandolfi L., Leo P., Solmi L., et al. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 32 6 (1991) 677-680
2. Reddy K.R., Kligerman S., Levi J., et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 67 2 (2001) 173-178
3. Trotter J.F., and Everson G.T. Benign focal lesions of the liver. Clin Liver Dis 5 1 (2001) 17-42
4. Gedaly R., Pomposelli J.J., Pomfret E.A., et al. Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg 134 4 (1999) 407-411
5. Karnam U.S., and Reddy K.R. Approach to the patient with a liver mass. In: Yamada T. (Ed). Textbook of gastroenterology. 4th edition (2003), Lippincott Williams & Wikins, Philadelphia 973-982
6. Harvey C.J., and Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 11 9 (2001) 1578-1593
7. Rubin R.A., and Lichtenstein G.R. Scintigraphic evaluation of liver masses: cavernous hepatic hemangioma. J Nucl Med 34 5 (1993) 849-852
8. Stark D.D., Felder R.C., Wittenberg J., et al. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. Am J Roentgenol 145 2 (1985) 213-222
9. Yoon S.S., Charny C.K., Fong Y., et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 197 3 (2003) 392-402
10. Mergo P.J., and Ros P.R. Benign lesions of the liver. Radiol Clin North Am 36 2 (1998) 319-331
11. Adam Y.G., Huvos A.G., and Fortner J.G. Giant hemangiomas of the liver. Ann Surg 172 2 (1970) 239-245
12. Conter R.L., and Longmire Jr. W.P. Recurrent hepatic hemangiomas. Possible association with estrogen therapy. Ann Surg 207 2 (1988) 115-119
13. Glinkova V., Shevah O., Boaz M., et al. Hepatic haemangiomas: possible association with female sex hormones. Gut 53 9 (2004) 1352-1355
14. Saegusa T., Ito K., Oba N., et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 34 3 (1995) 207-211
15. Farges O., Daradkeh S., and Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection?. World J Surg 19 1 (1995) 19-24
16. Bree R.L., Schwab R.E., Glazer G.M., et al. The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging, and scintigraphy. Radiographics 7 6 (1987) 1153-1175
17. Jang H.J., Kim T.K., Lim H.K., et al. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. Am J Roentgenol 180 1 (2003) 135-141
18. Quaia E., Calliada F., Bertolotto M., et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnosis performance and confidence. Radiology 232 2 (2004) 420-430
19. Wilson S.R., Burns P.N., Muradali D., et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215 1 (2000) 153-161
20. Tanaka S., Ioka T., Oshikawa O., et al. Dynamic sonography of hepatic tumors. Am J Roentgenol 177 4 (2001) 799-805
21. Marn C., Bree R., and Silver T. Ultrasonography of liver. Technique and focal and diffuse disease. Radiol Clin North Am 29 6 (1991) 1151-1170
22. Wen Y.L., Kudo M., Zheng R.Q., et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Am J Roentgenol 182 4 (2004) 1019-1026
23. Furuse J., Nagase M., Ishii H., et al. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 76 906 (2003) 385-392
24. Isozaki T., Numata K., Kiba T., et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229 3 (2003) 798-805
25. Yun E.J., Choi B.I., Han J.K., et al. Hepatic hemangioma: contrast-enhancement pattern during the arterial and portal venous phases of spiral CT. Abdom Imaging 24 3 (1999) 262-266
26. Yamashita Y., Ogata I., Urata J., et al. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 203 1 (1997) 121-125
27. van Leeuwen M.S., Noordzij J., Feldberg M.A., et al. Focal liver lesions: characterization with triphasic spiral CT. Radiology 201 2 (1996) 327-336
28. Powers C., Ros P.R., Stoupis C., et al. Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 14 3 (1994) 459-482
29. Bennett G.L., Petersein A., Mayo-Smith W.W., et al. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangioma from metastases. Am J Roentgenol 174 2 (2000) 477-485
30. Kumano S., Murakami T., Kim T., et al. Using superparamagnetic iron oxide-enhanced MRI to differential metastatic hepatic tumors and nonsolid benign lesions. Am J Roentgenol 181 5 (2003) 1335-1339
31. Soyer P., Gueye C., Somveille E., et al. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images. Am J Roentgenol 165 6 (1995) 1407-1413
32. el-Desouki M., Mohamadiyeh M., al-Rashed R., et al. Features of hepatic cavernous hemangioma on planar and SPECT Tc-99m-labeled red blood cell scintigraphy. Clin Nucl Med 24 8 (1999) 583-589
33. Hinshaw J.L., Laeseke P.J., Weber S.M., et al. Multiple-electrode radiofrequency ablation of symptomatic hepatic cavernous hemangioma. Am J Roentgenol 189 3 (2007) W146-W149
34. Silverman S.G., Tuncali K., Adams D.F., et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217 3 (2000) 657-664
35. Zagoria R.J., Roth T.J., Levine E.A., et al. Radiofrequency ablation of a symptomatic hepatic cavernous hemangioma. Am J Roentgenol 182 1 (2004) 210-212
36. Craig J.R., Peters R.L., and Edmonson H.A. Tumors of the liver and intrahepatic bile ducts. In: Hartmann W.H. (Ed). Atlas of tumor pathology. series 2 (1989), Armed Forces Institute of Pathology, Washington 63-101
37. Nguyen B.N., Flejou J.F., Terris B., et al. Focal nodular hyperplasia of the liver: a comprehensive pathological study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23 12 (1999) 1441-1454
38. Wanless I.R., Mawdsley C., and Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5 6 (1985) 1194-1200
39. Scalori A., Tavani A., Gallus S., et al. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 186 2 (2002) 195-197
40. Mathieu D., Kobeiter H., Maison P., et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 118 3 (2000) 560-564
41. Blonski W., and Reddy K.R. Evaluation of nonmalignant liver masses. Curr Gastroenterol Rep 8 1 (2006) 38-45
42. Kehagias D., Moulopoulos L., Antoniou A., et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 11 2 (2001) 202-212
43. Shamsi K., De Schepper A., Degryse H., et al. Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 18 1 (1993) 32-38
44. Carlson S.K., Johnson C.D., Bender C.E., et al. CT of focal nodular hyperplasia of the liver. Am J Roentgenol 174 3 (2000) 705-712
45. Caseiro-Alves F., Zins M., Mahfouz A.-E., et al. Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 198 3 (1996) 889-892
46. Blachar A., Federle M.P., Ferris J.V., et al. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology 223 2 (2002) 532-539
47. Cherqui D., Rahmouni A., Charlotte F., et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22 6 (1995) 1674-1681
48. Grazioli L., Morana G., Kirchin M.A., et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236 1 (2005) 166-177
49. Becker C.D., Gal I., Baer H.U., et al. Blunt hepatic trauma in adults: correlation of CT injury grading with outcome. Radiology 201 1 (1996) 215-220
50. Wanless I.R. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11 5 (1990) 787-797
51. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 12 4 (1990) 460-465
52. Reshamwala P.A., Kleiner D.E., and Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 44 1 (2006) 7-14
53. Ibarrola C., and Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 42 3 (2003) 251-264
54. Nzeako U.C., Goodman Z.D., and Ishak K.G. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol 91 5 (1996) 879-884
55. Dachman A.H., Ros P.R., Goodman Z.D., et al. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. Am J Roentgenol 148 4 (1987) 717-722
56. Rha S.E., Lee M.G., Lee Y.S., et al. Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome: CT and MR features. Abdom Imaging 25 3 (2000) 255-258
57. Al-Mukhaizeem K.A., Rosenberg A., and Sherker A.H. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 75 4 (2004) 225-230
58. Colombato L. The role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol 41 S3 (2007) S344-S351
59. Boyer T.D., Haskal Z.J., and American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 41 2 (2005) 386-400
60. Boyer T.D. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 10 1 (2008) 30-35
61. Faust D., Fellbaum C., Zeuzem S., et al. Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acid. Z Gastroenterol 41 3 (2003) 255-258
62. Terkivatan T., de Wilt J.H., de Man R.A., et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical approach. Arch Surg 136 9 (2001) 1033-1038
63. Weinmann A., Ringe B., Klempnauer J., et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21 9 (1997) 983-990
64. Ichikawa T., Federle M.P., Grazioli L., et al. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214 3 (2000) 861-868
65. Edmondson H.A., Henderson B., and Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294 9 (1976) 470-472
66. Carrasco D., Prieto M., Pallardó L., et al. Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature. J Hepatol 1 6 (1985) 573-578
67. Labrune P., Trioche P., Duvaltier I., et al. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24 3 (1997) 276-279
68. Gaffey M.J., Iezzoni J.C., and Weiss L.M. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148 4 (1996) 1089-1096
69. Kozyraki R., Scoazec J.Y., Flejou J.F., et al. Expression of cadherins and α-catenin in primary epithelial tumors of the liver. Gastroenterology 110 4 (1996) 1137-1149
70. Rebouissou S., Bioulac-Sage P., and Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48 1 (2008) 163-170
71. Laumonier H., Bioulac-Sage P., Laurent C., et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48 3 (2008) 808-818
72. de La Coste A., Romagnolo B., Billuart P., et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95 15 (1998) 8847-8851
73. Rooks J.B., Ory H.W., Ishak K.G., et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242 7 (1979) 644-648
74. Grazioli L., Federle M.P., Brancatelli G., et al. Hepatic adenomas: imaging and pathologic findings. Radiographics 21 4 (2001) 877-892
75. Rubin R.A., and Lichtenstein G.R. Hepatic scintigraphy in the evaluation of solitary solid liver masses. J Nucl Med 34 4 (1993) 697-705
76. Ferrell L.D. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol 17 5 (1993) 525-529
77. Foster J.H., and Berman M.M. The malignant transformation of liver cell adenomas. Arch Surg 129 7 (1994) 712-717
78. Krasinskas A.M., Eghtesad B., Kamath P.S., et al. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 11 6 (2005) 627-634
79. Zucman-Rossi J., Jeannot E., Nhieu J.T., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43 3 (2006) 515-524
80. Edmondson H.A., Reynolds T.B., Henderson B., et al. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86 2 (1977) 180-182
81. Estebe J.P., Malledant Y., Guillou Y.M., et al. [Spontaneous rupture of an adenoma of the liver during pregnancy]. J Chir (Paris) 125 11 (1988) 654-656
82. Parker P., Burr I., Slonim A., et al. Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology 81 3 (1981) 534-536
83. Regev A., Reddy K.R., Berho M., et al. Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center. J Am Coll Surg 193 1 (2001) 36-45
84. Nisenbaum H.L., and Rowling S.E. Ultrasound of focal hepatic lesions. Semin Roentgenol 30 4 (1995) 324-346
85. Cowles R.A., and Mulholland M.W. Solitary hepatic cysts. J Am Coll Surg 191 3 (2000) 311-321
86. Bahirwani R., and Reddy K.R. Review article: evaluation of solitary liver masses. Aliment Pharmacol Ther 28 (2008) 953-965
87. Martin I.J., McKinley A.J., Currie E.J., et al. Tailoring the management of nonparasitic liver cysts. Ann Surg 228 2 (1998) 167-172
88. Taylor B.R., and Langer B. Current surgical management of hepatic cyst disease. Adv Surg 31 (1997) 127-148
89. Spiegel R.M., King D.L., and Green W.M. Ultrasonography of primary cysts of the liver. Am J Roentgenol 131 2 (1978) 235-238
90. Kanzer G.K., and Weinreb J.C. Magnetic resonance imaging of diseases of the liver and biliary system. Radiol Clin North Am 29 6 (1991) 1259-1284
91. Saini S., Mueller P.R., Ferrucci Jr. J.T., et al. Percutaneous aspiration of hepatic cysts does not provide definitive therapy. Am J Roentgenol 141 3 (1983) 559-560
92. Alobaidi M., and Shirkhoda A. Benign focal liver lesions: discrimination from malignant mimickers. Curr Probl Diagn Radiol 33 6 (2004) 239-253
93. Ishak K.G., Willis G.W., Cummins S.D., et al. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 39 1 (1977) 322-338
94. Buetow P.C., Buck J.L., Pantongrag-Brown L., et al. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlation with emphasis on the importance of ovarian stroma. Radiology 196 3 (1995) 805-810
95. Choi B.I., Lim J.H., Han M.C., et al. Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. Radiology 171 1 (1989) 57-61
96. Korobkin M., Stephens D.H., Lee J.K., et al. Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. Am J Roentgenol 153 3 (1989) 507-511
97. Mortelé K.J., and Ros P.R. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21 4 (2001) 895-910